Physician profile
Timothy Le
NPI 1396409694
$3,827.38
in general payments reported to CMS, 2019-2025
23 companies · $1,847 in 2025
The $1,847 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $572 · 2024: $1,408 · 2025: $1,847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,820 · Education: $7.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,820.03 |
| Education | $7.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $668.69 | 2023-2025 | Prolate, Nalocet, Tanlor |
| Abbvie INC. | $591.14 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $553.88 | 2023-2025 | Relistor, Trulance |
| Astrazeneca Pharmaceuticals LP | $520.52 | 2023-2025 | Breztri, Airsupra, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $201.78 | 2024-2025 | |
| Novo Nordisk INC | $183.86 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Ani Pharmaceuticals, INC. | $161.00 | 2025 | Purified Cortrophin Gel |
| Vanda Pharmaceuticals INC. | $131.78 | 2024 | Fanapt |
| Curonix LLC | $122.59 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $107.13 | 2024-2025 | Caplyta |
| Pfizer INC. | $90.60 | 2023-2025 | |
| Lilly USA, LLC | $79.07 | 2023-2025 | Mounjaro, Emgality, Reyvow |
| Collegium Pharmaceutical, INC. | $74.69 | 2025 | Xtampza |
| Protega Pharmaceutials INC | $72.04 | 2025 | Roxybond |
| Dexcom, INC. | $68.29 | 2024-2025 | Dexcom G6 Transmitter |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $57.85 | 2023 | Givlaari |
| Exact Sciences Corporation | $32.32 | 2025 | Cologuard Collection Kit |
| Spr Therapeutics, INC | $21.27 | 2024 | Sprint Pns System |
| Axsome Therapeutics, INC. | $19.62 | 2024 | Auvelity |
| Scilex Pharmaceuticals INC. | $18.98 | 2025 | |
| Nalu Medical, INC. | $18.24 | 2024 | Nalu Neurostimulation System |
| Kyowa Kirin, INC. | $18.04 | 2023 | Crysvita |
| Corcept Therapeutics | $14.00 | 2025 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.